Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Intraperitoneal chemotherapy for epithelial ovarian cancer - single center experience.

Jaka RC, Somashekhar SP, Zaveri SS, Ahmed Z, Ashwin KR.

Indian J Surg Oncol. 2012 Sep;3(3):262-6. doi: 10.1007/s13193-012-0166-y. Epub 2012 Jul 4.

2.

Complications associated with 9-10Fr venous access port use in adjuvant intraperitoneal chemotherapy after a cytoreductive surgery in ovarian cancer patients.

Milczek T, Klasa-Mazurkiewicz D, Wydra D.

Adv Med Sci. 2015 Sep;60(2):216-9. doi: 10.1016/j.advms.2015.03.001. Epub 2015 Apr 1.

PMID:
25863871
3.

Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.

Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP.

Int J Gynecol Cancer. 2012 Feb;22(2):232-7. doi: 10.1097/IGC.0b013e318234f833.

PMID:
22080886
4.

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.

Barlin JN, Dao F, Bou Zgheib N, Ferguson SE, Sabbatini PJ, Hensley ML, Bell-McGuinn KM, Konner J, Tew WP, Aghajanian C, Chi DS.

Gynecol Oncol. 2012 Jun;125(3):621-4. doi: 10.1016/j.ygyno.2012.03.027. Epub 2012 Mar 21.

PMID:
22446622
5.

Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience.

Ivy JJ, Geller M, Pierson SM, Jonson AL, Argenta PA.

Gynecol Oncol. 2009 Sep;114(3):420-3. doi: 10.1016/j.ygyno.2009.05.036. Epub 2009 Jun 26.

PMID:
19560189
6.

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.

Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA.

Gynecol Oncol. 2010 Mar;116(3):340-4. doi: 10.1016/j.ygyno.2009.10.054. Epub 2009 Nov 17.

PMID:
19922987
7.

Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.

Chin SN, Pinto V, Rosen B, Oza A, Dodge J, Murphy J, Mackay H.

Gynecol Oncol. 2009 Mar;112(3):450-4. doi: 10.1016/j.ygyno.2008.11.021. Epub 2009 Jan 10.

PMID:
19135709
8.

Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer.

Konner JA, Grabon DM, Gerst SR, Iasonos A, Thaler H, Pezzulli SD, Sabbatini PJ, Bell-McGuinn KM, Tew WP, Hensley ML, Spriggs DR, Aghajanian CA.

J Clin Oncol. 2011 Dec 10;29(35):4662-8. doi: 10.1200/JCO.2011.36.1352. Epub 2011 Nov 7.

9.

An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.

Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.

Gynecol Oncol. 2009 Apr;113(1):63-7. doi: 10.1016/j.ygyno.2008.12.035. Epub 2009 Feb 7.

PMID:
19201457
10.

Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.

Lesnock JL, Richard SD, Zorn KK, Krivak TC, Beriwal S, Sukumvanich P, McBee WC Jr, Kelley JL, Edwards RP.

Gynecol Oncol. 2010 Mar;116(3):345-50. doi: 10.1016/j.ygyno.2009.11.009. Epub 2009 Dec 2.

PMID:
19959211
11.
12.

Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.

Zeimet AG, Reimer D, Radl AC, Reinthaller A, Schauer C, Petru E, Concin N, Braun S, Marth C.

Anticancer Res. 2009 Jul;29(7):2803-8. Review.

13.

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.

Fujiwara K, Sakuragi N, Suzuki S, Yoshida N, Maehata K, Nishiya M, Koshida T, Sawai H, Aotani E, Kohno I.

Gynecol Oncol. 2003 Sep;90(3):637-43. Erratum in: Gynecol Oncol. 2003 Dec;91(3):662.

PMID:
13678738
14.

Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study.

Oaknin A, Roda D, González-Martín A, Chiva L, García-Donas J, de Juan A, Redondo A, Martínez S, García Y, Catot S, Ponce J, Del Campo JM, Cervantes A, Poveda A.

Int J Gynecol Cancer. 2011 Aug;21(6):1048-55. doi: 10.1097/IGC.0b013e31821ee777.

PMID:
21738038
15.

Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.

Suidan RS, Zhou Q, Iasonos A, O'Cearbhaill RE, Chi DS, Long Roche KC, Tanner EJ, Denesopolis J, Barakat RR, Zivanovic O.

Int J Gynecol Cancer. 2015 May;25(4):599-606. doi: 10.1097/IGC.0000000000000389.

16.

Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.

Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S.

Gynecol Oncol. 2012 Oct;127(1):51-4. doi: 10.1016/j.ygyno.2012.05.026. Epub 2012 May 30.

PMID:
22659193
17.

It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.

Henretta MS, Anderson CL, Angle JF, Duska LR.

Gynecol Oncol. 2011 Nov;123(2):342-5. doi: 10.1016/j.ygyno.2011.07.031. Epub 2011 Aug 15.

PMID:
21840583
18.

Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.

Aziz Z, Zahid M, Ud Din Ahmed Z, Arshad T.

Aust N Z J Med. 1998 Jun;28(3):403-9.

PMID:
9673759
19.

Toxicity of intraperitoneal chemotherapy and risk factors for severe toxicity in optimally debulked ovarian cancer patients.

Koo YJ, Lim KT.

Taiwan J Obstet Gynecol. 2015 Jun;54(3):275-9. doi: 10.1016/j.tjog.2013.12.010.

20.

Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer.

Battelli C, Campo M, Buss MK, Awtrey CS, Konstantinopoulos PA.

Chemotherapy. 2013;59(4):251-9. doi: 10.1159/000356758. Epub 2014 Jan 17.

PMID:
24457572

Supplemental Content

Support Center